Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
Cipla Limited (CIPLA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The CIPLA share price is ₹1,409.00 (-0.14% today), with a market capitalisation of ₹1.14T and a price-to-earnings (P/E) ratio of 39.2. MarketRipple tracks the CIPLA investment thesis, the ripple-chain impact of market events on Cipla Limited, and the Healthcare sector outlook.
Open
₹1,408.00
High
₹1,421.40
Low
₹1,402.50
Prev. Close
₹1,411.00
52W High
₹1,539.70
52W Low
₹1,165.70
Day range
₹1,402.50–₹1,421.40
52-week range
₹1,165.70–₹1,539.70
Volume
477K
P/E
39.2
ROE
8.3%
D/E
0.02
Margin
10.4%
Cipla Limited (NSE: CIPLA) is currently trading at ₹1,409.00 (-0.14%).
Cipla Limited's market capitalization is ₹1.14T.
Cipla Limited's price-to-earnings (P/E) ratio is 39.2.
Cipla Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Cipla Limited currently reads positive, based on 36 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.